Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

about

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

Item

http://www.wikidata.org/entity/Q49526759

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

@en

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

@nl

type

Item

label

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

@en

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

@nl

prefLabel

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

@en

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

@nl

P1476

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017

@en

P2093

Benjamin Pradère

http://www.w3.org/2001/XMLSchema#string

Benoit Peyronnet

http://www.w3.org/2001/XMLSchema#string

Constance Thibault

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Leow

http://www.w3.org/2001/XMLSchema#string

Morgan Rouprêt

http://www.w3.org/2001/XMLSchema#string

Thomas Seisen

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Neo-adjuvant chemotherapy for invasive bladder cancer

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity

P304

1049-1059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2017.09.12

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Malte W Vetterlein

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29354492

http://www.w3.org/2001/XMLSchema#string

P932

5760386

http://www.w3.org/2001/XMLSchema#string